HempNewsBreaks – AppSwarm, Inc. (SWRM) Applies Technical Expertise to Enter Cannabis Mobile App Market with Partner SinglePoint, Inc. (SING)

Developer and publisher of mobile gaming apps AppSwarm, Inc. (OTC: SWRM) is utilizing its technical expertise to enter the cannabis mobile app market in partnership with SinglePoint, Inc. (OTC: SING). An article discussing this reads: “As the two companies join forces, described in the LOI, it provides SWRM a significant platform for providing its technical and app development knowledge. They will first develop a service-based app for the business-to-business and business-to-consumer markets and provide a base for the development of future apps. The products will represent SWRM’s entry into the cannabis market and will be branded and marketed under SinglePoint’s SingleSeed subsidiary. Cannabis is a large and growing market, projected to reach $50 billion by 2025 (http://cnw.fm/O3cCT). The jointly-developed apps will be available in all states where legal and feasible, the companies announced.”

To view the full article, visit http://cnw.fm/WwZ3T

About AppSwarm

AppSwarm develops and publishes mobile gaming apps, with a focus on accelerating the development of free to play mobile games and fast-track them to market. The company partners with game developers through joint ventures, royalty agreements, marketing partnerships, and outright purchases through its publicly-traded company on the OTC Markets, ticker SWRM. For more information, visit www.App-Swarm.com

More from CannabisNewsBreaks

About HempWire

HempWire (HW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) HempNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, HW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. HW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, HW brings its clients unparalleled visibility, recognition and brand awareness. HW is where news, content and information converge.

For more information please visit https://www.hempwire.com

Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.hempwire.com/disclaimer/

HempWire (HW)
Denver, Colorado
www.hempwire.com
303.498.7722 Office
Editor@HempWire.net

Chris@HW

Share
Published by
Chris@HW

Recent Posts

HempNewsBreaks – Turning Point Brands Inc. (NYSE: TPB) Closes $300M Senior Secured Notes Offering 

Turning Point Brands (NYSE: TPB), a manufacturer, marketer and distributor of branded consumer products, recently…

2 months ago

HempNewsBreaks – WEED Inc. (BUDZ) Announces 2024 Highlights, Plans to Expand into Consumer Packaged Goods

WEED Inc. (OTCQB: BUDZ), a global cannabis and hemp bioresearch company based in the U.S.,…

4 months ago

HempNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Closes $3.6M Registered Direct

Flora (NASDAQ: FLGC) has closed a registered direct offering to institutional investors for the aggregate…

4 months ago

HempNewsBreaks – Golden Triangle Ventures Inc. (GTVH) to Host Spaces Event, Share Comprehensive Update on Destino Ranch

Golden Triangle Ventures (OTC: GTVH) (“GTV”) today announced its plans to host a Spaces call…

5 months ago

HempNewsBreaks – CBD Life Sciences Inc. (CBDL) Poised to Become Game Changer in the Hemp Industry

CBD Life Sciences (OTC: CBDL) today announced its potential for explosive profits in a $70…

6 months ago

HempNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Cleared to Begin Human Pilot Study #3 Evaluating DehydraTECH-Processed Tirzepatide

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, announced Friday that…

7 months ago